Physician profile
James D Gardner
NPI 1497718092
$2,458.36
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $1,079 · 2021: $989 · 2022: $15.73.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $436.33 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $333.30 | 2019-2021 | |
| Lilly USA, LLC | $279.51 | 2019-2021 | |
| Pfizer INC. | $150.12 | 2019-2021 | |
| Glaxosmithkline, LLC. | $121.40 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $120.06 | 2019-2021 | |
| Abbvie INC. | $119.94 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $107.53 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $100.64 | 2020-2021 | |
| Eisai INC. | $99.13 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.97 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $66.82 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $63.80 | 2019-2021 | |
| Amarin Pharma, INC. | $50.62 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $46.36 | 2020-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $32.43 | 2020 | |
| Janssen Pharmaceuticals, INC | $25.95 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $25.59 | 2020-2021 | |
| Lundbeck LLC | $22.31 | 2020 | |
| Kyowa Kirin, INC. | $19.28 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.25 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.46 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $16.20 | 2021 | |
| Biogen, INC. | $14.74 | 2021 | |
| Collegium Pharmaceutical, INC. | $14.38 | 2021 | |
| Astellas Pharma US INC | $13.91 | 2019 | |
| Tactile Systems Technology INC | $13.55 | 2021 | |
| Mylan Specialty L.P. | $12.68 | 2020 | |
| Amgen INC. | $12.43 | 2021 | |
| Circassia INC. | $12.00 | 2019 | |
| Allergan, INC. | $11.67 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.